Cargando…

1600P Suboptimal response to COVID-19 mRNA vaccines in older patients with cancer

Detalles Bibliográficos
Autores principales:	Landre, T., Bouharati, D., Amara, M. Ait, Taleb, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society for Medical Oncology. Published by Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454325/ http://dx.doi.org/10.1016/j.annonc.2021.08.1593

Ejemplares similares

Suboptimal response to COVID-19 mRNA vaccines in hematologic malignancies patients
por: Agha, Mounzer, et al.
Publicado: (2021)

Can Individuals with Suboptimal Antibody Responses to Conventional Antiviral Vaccines Acquire Adequate Antibodies from SARS-CoV-2 mRNA Vaccination?
por: Ogura, Wataru, et al.
Publicado: (2022)

Post-RNA (mRNA) Vaccination Myocarditis: CMR Features
por: Das, Karuna M., et al.
Publicado: (2022)

Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine
por: Palumbo, Giuseppe A., et al.
Publicado: (2023)

Frailty impacts immune responses to Moderna COVID-19 mRNA vaccine in older adults
por: Semelka, Charles T., et al.
Publicado: (2023)

Antibody responses to mRNA versus non-mRNA COVID vaccines among the Mongolian population
por: Sereejav, Enkhbold, et al.
Publicado: (2023)

Suboptimal antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients
por: Al Jurdi, Ayman, et al.
Publicado: (2022)

Poor vaccine responsiveness towards third-dose mRNA vaccine of COVID-19 in Japanese older people
por: Hagiya, Hideharu, et al.
Publicado: (2022)

Calderón, 1600-2000 /
Publicado: (2002)

Fable, c. 1600
por: Potter, Polyxeni
Publicado: (2002)

Myocarditis following COVID‐19 mRNA (mRNA‐1273) vaccination
por: Chellapandian, Suresh Babu, et al.
Publicado: (2022)

COVID-19 mRNA vaccines
por: Huang, Qingrui, et al.
Publicado: (2021)

COVID-19 mRNA Vaccination
por: Vered, Livneh, et al.
Publicado: (2022)

Dynamics of T-cell Responses Following COVID-19 mRNA Vaccination and Breakthrough Infection in Older Adults
por: Datwani, Sneha, et al.
Publicado: (2023)

Temporal metabolic response and mRNA COVID-19 vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

Minimal mRNA uptake and inflammatory response to COVID-19 mRNA vaccine exposure in human placental explants
por: Gonzalez, Veronica, et al.
Publicado: (2023)

Minimal mRNA uptake and inflammatory response to COVID-19 mRNA vaccine exposure in human placental explants
por: Gonzalez, Veronica J., et al.
Publicado: (2023)

mRNA as a Therapeutics: Understanding mRNA Vaccines
por: Oğuz, Ferdi, et al.
Publicado: (2022)

mRNA Vaccine Platform: mRNA Production and Delivery
por: Litvinova, V. R., et al.
Publicado: (2023)

Observation of the $\varrho$'(1600) in the channel $\gamma$p --> $\pi^{+}\pi^{-}$p
por: Aston, D, et al.
Publicado: (1980)

Antibody Responses After mRNA-Based COVID-19 Vaccination in Residential Older Adults: Implications for Reopening
por: Nace, David A., et al.
Publicado: (2021)

Reduced Magnitude and Durability of Humoral Immune Responses to COVID-19 mRNA Vaccines Among Older Adults
por: Brockman, Mark A, et al.
Publicado: (2021)

Catálogo novogalaico, 1600-1650 /
por: Hernández Bermejo, Evelia
Publicado: (1999)

The language of the heart, 1600–1750
por: Rousseau, G S
Publicado: (1998)

Obstetrics in Mexico Prior to 1600
por: Van Patten, Nathan
Publicado: (1932)

Spontaneous Intracranial Hypotension Complicated by a Cerebral Venous Thrombosis Following an mRNA Covid-19 Vaccination: Coincidence vs Cause?
por: Pandey, Anoop Kumar, et al.
Publicado: (2023)

Heterogeneous Longitudinal Antibody Responses to Covid-19 mRNA Vaccination
por: de la Monte, Suzanne M, et al.
Publicado: (2021)

Response to mRNA COVID-19 vaccination in three XLA patients
por: Squire, J.D., et al.
Publicado: (2022)

Shingles and mRNA COVID‐19 vaccine
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Commentary of the mRNA vaccines COVID-19
por: Vitiello, Antonio, et al.
Publicado: (2021)

Myocarditis and COVID-19 mRNA vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

COVID-19 mRNA Vaccine and Myocarditis
por: Singh, Balraj, et al.
Publicado: (2021)

COVID‐19 mRNA vaccines and myopericarditis
por: Gnanenthiran, Sonali R., et al.
Publicado: (2022)

Reactogenicity to the mRNA-1273 Booster According to Previous mRNA COVID-19 Vaccination
por: Parés-Badell, Oleguer, et al.
Publicado: (2022)

OAB-048: Suboptimal humoral immune response to SARS-CoV-2 mRNA vaccination in myeloma patients is associated with anti-CD38 mAb and BCMA-targeted treatment
por: Oekelen, Oliver Van, et al.
Publicado: (2021)

P1600: ANTIGENS OF THE DUFFY BLOOD GROUP SYSTEM AND RISK OF COVID-19 INFECTION
por: Poponina, E., et al.
Publicado: (2022)

Dangers of mRNA vaccines
por: Ali, Tahoora, et al.
Publicado: (2021)

mRNA-Based Vaccines
por: Kowalzik, Frank, et al.
Publicado: (2021)

Advances in mRNA vaccines
por: Li, Mengyun, et al.
Publicado: (2022)

Signs of immunosenescence correlate with poor outcome of mRNA COVID-19 vaccination in older adults
por: Palacios-Pedrero, Miguel Ángel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c5v57uel8f6lvnb04ldv2vmbhl